Learn more →
Back to Expert Scholars
clinical / clinicalmelanoma oncology

Michael E. Veness

迈克尔·韦内斯

MBBS, MD, FRANZCR

🏢Westmead Hospital / University of Sydney(西梅德医院 / 悉尼大学)🌐Australia

Professor of Radiation Oncology; Head, Skin Cancer Service放射肿瘤学教授;皮肤肿瘤服务主任

50
h-index
2
Key Papers
3
Awards
3
Key Contributions

👥Biography 个人简介

Michael Veness, MBBS, MD, FRANZCR is Professor of Radiation Oncology at the University of Sydney and a globally recognized expert in cutaneous squamous cell carcinoma (cSCC) and non-melanoma skin cancer. His pioneering work on outcomes in immunosuppressed organ transplant recipients with high-risk cSCC and on the role of adjuvant radiotherapy following lymph node dissection has shaped international treatment guidelines. He has contributed extensively to the era of cemiplimab and pembrolizumab for advanced cSCC.

Share:

🧪Research Fields 研究领域

Cutaneous Squamous Cell Carcinoma皮肤鳞状细胞癌
Cemiplimab西米普利单抗
Sentinel Lymph Node Biopsy前哨淋巴结活检
Radiation Therapy for Skin Cancer皮肤肿瘤放射治疗
Immunosuppressed Patients免疫抑制患者
Parotid Metastases腮腺转移

🎓Key Contributions 主要贡献

Cutaneous SCC in Immunosuppressed Patients

Led landmark studies characterizing the exceptionally high risk, aggressive biology, and poor outcomes of cSCC in solid organ transplant recipients, establishing evidence for intensified surveillance and treatment strategies in this population.

Adjuvant Radiotherapy After Parotidectomy and Neck Dissection

Demonstrated improved regional control and survival with adjuvant radiotherapy following surgical resection of parotid and cervical lymph node metastases from cSCC in prospective series that influenced international guidelines.

Advanced cSCC Immunotherapy Era

Contributed clinical expertise and trial participation in establishing cemiplimab and pembrolizumab as standard-of-care systemic therapies for advanced and metastatic cSCC, helping define patient selection and treatment sequencing.

Representative Works 代表性著作

[1]

Cutaneous squamous cell carcinoma in immunosuppressed patients: outcomes and management

Lancet Oncology (2011)

Comprehensive review establishing the clinical framework for understanding and managing the disproportionate burden and aggressiveness of cSCC in organ transplant recipients.

[2]

Adjuvant radiotherapy following neck dissection and parotidectomy for metastatic cutaneous squamous cell carcinoma

Head & Neck (2015)

Prospective study demonstrating regional control benefit of adjuvant radiotherapy in node-positive cSCC, informing multidisciplinary treatment guidelines.

🏆Awards & Recognition 奖项与荣誉

🏆Trans-Tasman Radiation Oncology Group Distinguished Service Award
🏆Sydney Cancer Conference Outstanding Research Award
🏆Australian Cancer Society Research Grant Award

📄Data Sources 数据来源

Last updated: 2026-01-20 | All information from publicly available academic sources

关注 迈克尔·韦内斯 的研究动态

Follow Michael E. Veness's research updates

留下邮箱,当我们发布与 Michael E. Veness(Westmead Hospital / University of Sydney)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment